Clinical Trial Update: A Study of Ketamine in Patients With Treatment-resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ketamine for treatment-resistant major depressive disorder has completed, and results were posted. The trial update comes from Jansse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2016-08-05